WFM
EW icon

Wilmington Funds Management’s Edwards Lifesciences EW Stock Holding History

Wilmington Funds Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$334K Buy
+23,316
New +$316K 0.03% 495
2013
Q4 		– Sell
-19,716
Closed -$229K – 802
2013
Q3 		$229K Hold
19,716
– – 0.02% 644
2013
Q2 		$221K Buy
+19,716
New +$233K 0.02% 621

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Funds Management's EW Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Edwards Lifesciences (EW) in Q2 2014: 23,316 shares worth $334K. The stake represents 0.03% of the portfolio and ranks #495 among its holdings. This is a return to the name: Wilmington Funds Management previously reported a position in EW as recently as Q3 2013.

Wilmington Funds Management first reported a position in EW in Q2 2013 and has held it in 3 quarters since. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Wilmington Funds Management held 23,316 shares of Edwards Lifesciences worth $334K as of Q2 2014.
  • Edwards Lifesciences was a new Wilmington Funds Management position in Q2 2014.
  • Edwards Lifesciences made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #495 holding.
  • Wilmington Funds Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 3 quarters since.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.